EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LncRNA NRAV is associated with unfavorable prognosis and immune-related transcriptional features in hepatocellular carcinoma

Xingbao Fang, Yan Cai, Zhaojun Li, Xiongbing Peng, Shaohua Yang, Zhuoyu Zhao, Yuehong Li

Discover Oncology · 09.06.2026 · 17 (1)

DOI: 10.1007/s12672-026-05331-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 09.06.2026. Verfasst von Xingbao Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Pancreatic Surgery, The First People's Hospital of Qujing, No. 1 Yuanlin Road, Qilin District, Qujing, 655000, Yunnan, Ch…. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Joint Special Project for Basic Research of Yunnan Provincial Department of Science and Technology and Kunming Medical University, the Scientific Research Fund of Qujing Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerHepatocellular carcinomaImmune checkpointImmune infiltrationNRAVPrognosis

Autor:innen und Institutionen

  • Department of Hepatobiliary Pancreatic Surgery, The First People's Hospital of Qujing, No. 1 Yuanlin Road, Qilin District, Qujing, 655000, Yunnan, China.
  • Qujing University of Medicine and Health Sciences, No. 1 Longhu East Road, Tongquan Subdistrict, Malong District, Qujing, 655000, Yunnan, China.
  • Department of Hepatobiliary Pancreatic Surgery, The First People's Hospital of Qujing, No. 1 Yuanlin Road, Qilin District, Qujing, 655000, Yunnan, China. liyuehong@kmmu.edu.cn.
  • Qujing University of Medicine and Health Sciences, No. 1 Longhu East Road, Tongquan Subdistrict, Malong District, Qujing, 655000, Yunnan, China. liyuehong@kmmu.edu.cn.

Förderung

  • the Joint Special Project for Basic Research of Yunnan Provincial Department of Science and Technology and Kunming Medical University
  • the Scientific Research Fund of Qujing Medical College

Zitieren

APA

Fang, X., Cai, Y., Li, Z., Peng, X., Yang, S., Zhao, Z., & Li, Y. (2026). LncRNA NRAV is associated with unfavorable prognosis and immune-related transcriptional features in hepatocellular carcinoma. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-05331-3

Vancouver

Fang X, Cai Y, Li Z, Peng X, Yang S, Zhao Z, et al. LncRNA NRAV is associated with unfavorable prognosis and immune-related transcriptional features in hepatocellular carcinoma. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-05331-3

BibTeX
@article{Fang2026,
  author = {Fang, Xingbao and Cai, Yan and Li, Zhaojun and Peng, Xiongbing and Yang, Shaohua and Zhao, Zhuoyu and Li, Yuehong},
  title = {LncRNA NRAV is associated with unfavorable prognosis and immune-related transcriptional features in hepatocellular carcinoma},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-05331-3}
}
Kostenlos starten →